Advertisement

Related Videos

Peter Clark, MA, MD, FRCP: A Payer Perspective

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Advertisement

Advertisement




Jun
16
Today In Oncology
Neoadjuvant Sacituzumab Govitecan in MIBC
Thyroid Cancer Reproductive Lifespan, Hormone Therapy Potentially Linked to Incidence
Two-Pronged Nudges Result in Timely Conversations Around Priorities of Cancer Care
MIBC Intravesical Recombinant BCG and Chemoimmunotherapy
Overall Survival Benefit With Ivonescimab Plus Chemotherapy in Advanced Squamous NSCLC
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo